The latest study on Immunomodulators Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Immunomodulators Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Immunomodulators and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Abbott
Eli Lilly and Company
Biogen
Amgen Inc.
Novartis AG
Merck & Co. Inc.
Roche
Johnson & Johnson
Bristol-Myers Squibb Company
Immunomodulators Market Analysis By Type Segment:
Immunosuppressant
Immunostimulants
Immunomodulators Market Analysis By Application Segment:
Oncology
Respiratory
HIV
Others
The Immunomodulators Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Immunomodulators Report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Immunomodulators Market:
Immunomodulators market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Immunomodulators Market
What is the expected Market size and growth rate of the Immunomodulators market for the forecast period
Where is the largest and fastest growing market for Immunomodulators market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Immunomodulators market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Immunomodulators Market status and future forecast.
To present the key Immunomodulators Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Frequently Asked Questions - FAQ:
How big is the opportunity for the Immunomodulators market
Which are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Immunomodulators market Which companies are the front runners
What are the major end-use industries of Immunomodulators market
Feel free to contact us for Customisation, Request For Free Sample, Ask for discount
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Immunomodulators Market Size Growth Rate by Type (2021-2027)
1.3.2 Immunosuppressant
1.3.3 Immunostimulants
1.4 Market Segment by Application
1.4.1 Global Immunomodulators Market Share by Application (2021-2027)
1.4.2 Oncology
1.4.3 Respiratory
1.4.4 HIV
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunomodulators Market Size
2.1.1 Global Immunomodulators Revenue 2016-2027
2.1.2 Global Immunomodulators Sales 2016-2027
2.2 Immunomodulators Growth Rate by Regions
2.2.1 Global Immunomodulators Sales by Regions 2016-2020
2.2.2 Global Immunomodulators Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Immunomodulators Sales by Manufacturers
3.1.1 Immunomodulators Sales by Manufacturers 2016-2020
3.1.2 Immunomodulators Sales Market Share by Manufacturers 2016-2020
3.2 Revenue by Manufacturers
3.2.1 Immunomodulators Revenue by Manufacturers (2016-2020)
3.2.2 Immunomodulators Revenue Share by Manufacturers (2016-2020)
3.2.3 Global Immunomodulators Market Concentration Ratio (CR5 and HHI)
3.3 Immunomodulators Price by Manufacturers
3.4 Key Manufacturers Immunomodulators Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Immunomodulators Market
3.6 Key Manufacturers Immunomodulators Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Immunosuppressant Sales and Revenue (2016-2020)
4.1.2 Immunostimulants Sales and Revenue (2016-2020)
4.2 Global Immunomodulators Sales Market Share by Type
4.3 Global Immunomodulators Revenue Market Share by Type
4.4 Immunomodulators Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Immunomodulators Sales by Application
6 United States
6.1 United States Immunomodulators Breakdown Data by Company
6.2 United States Immunomodulators Breakdown Data by Type
6.3 United States Immunomodulators Breakdown Data by Application
7 European Union
7.1 European Union Immunomodulators Breakdown Data by Company
7.2 European Union Immunomodulators Breakdown Data by Type
7.3 European Union Immunomodulators Breakdown Data by Application
8 China
8.1 China Immunomodulators Breakdown Data by Company
8.2 China Immunomodulators Breakdown Data by Type
8.3 China Immunomodulators Breakdown Data by Application
9 Rest of World
9.1 Rest of World Immunomodulators Breakdown Data by Company
9.2 Rest of World Immunomodulators Breakdown Data by Type
9.3 Rest of World Immunomodulators Breakdown Data by Application
9.4 Rest of World Immunomodulators Breakdown Data by Countries
9.4.1 Rest of World Immunomodulators Sales by Countries
9.4.2 Rest of World Immunomodulators Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Immunomodulators
10.1.4 Immunomodulators Product Introduction
10.1.5 Roche Recent Development
10.2 Amgen Inc.
10.2.1 Amgen Inc. Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Immunomodulators
10.2.4 Immunomodulators Product Introduction
10.2.5 Amgen Inc. Recent Development
10.3 Abbott
10.3.1 Abbott Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Immunomodulators
10.3.4 Immunomodulators Product Introduction
10.3.5 Abbott Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Immunomodulators
10.4.4 Immunomodulators Product Introduction
10.4.5 Johnson & Johnson Recent Development
10.5 Novartis AG
10.5.1 Novartis AG Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Immunomodulators
10.5.4 Immunomodulators Product Introduction
10.5.5 Novartis AG Recent Development
10.6 Eli Lilly and Company
10.6.1 Eli Lilly and Company Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Immunomodulators
10.6.4 Immunomodulators Product Introduction
10.6.5 Eli Lilly and Company Recent Development
10.7 Bristol-Myers Squibb Company
10.7.1 Bristol-Myers Squibb Company Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Immunomodulators
10.7.4 Immunomodulators Product Introduction
10.7.5 Bristol-Myers Squibb Company Recent Development
10.8 Merck & Co. Inc.
10.8.1 Merck & Co. Inc. Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Immunomodulators
10.8.4 Immunomodulators Product Introduction
10.8.5 Merck & Co. Inc. Recent Development
10.9 Biogen
10.9.1 Biogen Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Immunomodulators
10.9.4 Immunomodulators Product Introduction
10.9.5 Biogen Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Immunomodulators Sales Channels
11.2.2 Immunomodulators Distributors
11.3 Immunomodulators Customers
12 Market Forecast
12.1 Global Immunomodulators Sales and Revenue Forecast 2021-2027
12.2 Global Immunomodulators Sales Forecast by Type
12.3 Global Immunomodulators Sales Forecast by Application
12.4 Immunomodulators Forecast by Regions
12.4.1 Global Immunomodulators Sales Forecast by Regions 2021-2027
12.4.2 Global Immunomodulators Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Immunomodulators Product Picture
Table Immunomodulators Key Market Segments
Table Major Manufacturers Immunomodulators Covered in This Report
Table Global Immunomodulators Market Size Growth Rate by Type 2021-2027 (MT) & (Million US$)
Figure Global Immunomodulators Sales Market Shar by Type 2016-2027
Figure Immunosuppressant Figures
Table Major Manufacturers of Immunosuppressant
Figure Immunostimulants Figures
Table Major Manufacturers of Immunostimulants
Table Global Immunomodulators Market Share by Application 2021-2027 (MT)
Figure Oncology Use Case
Figure Respiratory Use Case
Figure HIV Use Case
Figure Others Use Case
Figure Immunomodulators Report Years Considered
Figure Global Immunomodulators Market Size 2016-2027 (Million US$)
Figure Global Immunomodulators Sales 2016-2020 (MT)
Table Global Immunomodulators Market Size by Regions 2016-2020 (MT) & (Million US$)
Table Global Immunomodulators Sales by Regions 2016-2020 (MT)
Table Global Immunomodulators Sales Market Share by Regions 2016-2020
Figure Global Immunomodulators Sales Market Share by Regions 2016-2020
Figure Global Immunomodulators Sales Market Share by Regions in 2020
Table Global Immunomodulators Revenue by Regions 2016-2020 (Million US$)
Table Global Immunomodulators Revenue Market Share by Regions 2016-2020
Figure Global Immunomodulators Revenue Market Share by Regions 2016-2020
Figure Global Immunomodulators Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Immunomodulators Sales by Manufacturers (2016-2020) (MT)
Table Global Immunomodulators Sales Share by Manufacturers (2016-2020)
Figure Global Immunomodulators Sales Share by Manufacturers in 2020
Table Immunomodulators Revenue by Manufacturers (2016-2020) (Million USD)
Table Immunomodulators Revenue Share by Manufacturers (2016-2020)
Figure Immunomodulators Value Share by Manufacturers in 2020
Table Global Immunomodulators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Immunomodulators Price (2016-2020) (USD/Kg)
Table Key Manufacturers Immunomodulators Plants/Factories Distribution
Table Key Manufacturers Immunomodulators Area Served
Table Date of Key Manufacturers Enter into Immunomodulators Market
Table Key Manufacturers Immunomodulators Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Immunosuppressant Sales and Revenue (2016-2020) (MT) & (Million US$)
Table Global Immunostimulants Sales and Revenue (2016-2020) (MT) & (Million US$)
Table Global Immunomodulators Sales by Type (2016-2020) (MT)
Table Global Immunomodulators Sales Share by Type (2016-2020)
Figure Global Immunomodulators Sales Market Share by Type (2016-2020)
Figure Global Immunomodulators Sales Market Share by Type in 2020
Table Global Immunomodulators Revenue by Type (2016-2020) (Million US$)
Table Global Immunomodulators Revenue Share by Type (2016-2020)
Figure Global Immunomodulators Revenue Market Share by Type (2016-2020)
Figure Global Immunomodulators Revenue Market Share by Type in 2020
Table Immunomodulators Price by Type 2016-2020 (USD/Kg)
Table Global Immunomodulators Sales by Application (2016-2020) (MT)
Table Global Immunomodulators Sales Share by Application (2016-2020)
Figure Global Sales Immunomodulators Market Share by Application (2016-2020)
Figure Global Sales Immunomodulators Market Share by Application (2016-2020)
Figure United States Immunomodulators Sales Growth Rate 2016-2020 (MT)
Figure United States Immunomodulators Revenue Growth Rate 2016-2020 (Million US$)
Table United States Immunomodulators Sales by Company (2016-2020) (MT)
Table United States Immunomodulators Sales Market Share by Company (2016-2020)
Figure United States Immunomodulators Sales Market Share by Company in 2020
Table United States Immunomodulators Sales by Type (2016-2020) (MT)
Table United States Immunomodulators Sales Market Share by Type (2016-2020)
Figure United States Immunomodulators Market Share by Type in 2020
Table United States Immunomodulators Sales by Application (2016-2020) (MT)
Table United States Immunomodulators Sales Market Share by Application (2016-2020)
Figure United States Immunomodulators Market Share by Application in 2020
Figure European Union Immunomodulators Sales Growth Rate 2016-2020 (MT)
Figure European Union Immunomodulators Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Immunomodulators Sales by Company (2016-2020) (MT)
Table European Union Immunomodulators Sales Market Share by Company (2016-2020)
Figure European Union Immunomodulators Sales Market Share by Company in 2020
Table European Union Immunomodulators Sales by Type (2016-2020) (MT)
Table European Union Immunomodulators Sales Market Share by Type (2016-2020)
Figure 2020 European Union Immunomodulators Market Share by Type
Table European Union Immunomodulators Sales by Application (2016-2020) (MT)
Table European Union Immunomodulators Sales Market Share by Application (2016-2020)
Figure 2020 European Union Immunomodulators Market Share by Application
Figure China Immunomodulators Sales Growth Rate 2016-2020 (MT)
Figure China Immunomodulators Revenue Growth Rate 2016-2020 (Million US$)
Table China Immunomodulators Sales by Company (2016-2020) (MT)
Table China Immunomodulators Sales Market Share by Company (2016-2020)
Figure China Immunomodulators Sales Market Share by Company in 2020
Table China Immunomodulators Sales by Type (2016-2020) (MT)
Table China Immunomodulators Sales Market Share by Type (2016-2020)
Figure China Immunomodulators Market Share by Type in 2020
Table China Immunomodulators Sales by Application (2016-2020) (MT)
Table China Immunomodulators Sales Market Share by Application (2016-2020)
Figure China Immunomodulators Market Share by Application in 2020
Figure Rest of World Immunomodulators Sales Growth Rate 2016-2020 (MT)
Figure Rest of World Immunomodulators Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Immunomodulators Sales by Company (2016-2020) (MT)
Table Rest of World Immunomodulators Sales Market Share by Company (2016-2020)
Figure Rest of World Immunomodulators Sales Market Share by Company in 2020
Table Rest of World Immunomodulators Sales by Type (2016-2020) (MT)
Table Rest of World Immunomodulators Sales Market Share by Type (2016-2020)
Figure Rest of World Immunomodulators Market Share by Type in 2020
Table Rest of World Immunomodulators Sales by Application (2016-2020) (MT)
Table Rest of World Immunomodulators Sales Market Share by Application (2016-2020)
Figure Rest of World Immunomodulators Market Share by Application in 2020
Table Rest of World Immunomodulators Sales by Countries (2016-2020) (MT)
Table Rest of World Immunomodulators Sales Market Share by Countries (2016-2020)
Figure Rest of World Immunomodulators Sales Market Share by Countries in 2020
Table Rest of World Immunomodulators Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Immunomodulators Revenue Market Share by Countries (2016-2020)
Figure Rest of World Immunomodulators Revenue Market Share by Countries in 2020
Figure Japan Immunomodulators Sales Growth Rate (2016-2020) (MT)
Figure Japan Immunomodulators Revenue Growth Rate (2016-2020) (MT)
Figure Korea Immunomodulators Sales Growth Rate (2016-2020) (MT)
Figure Korea Immunomodulators Revenue Growth Rate (2016-2020) (MT)
Figure India Immunomodulators Sales Growth Rate (2016-2020) (MT)
Figure India Immunomodulators Revenue Growth Rate (2016-2020) (MT)
Figure Southeast Asia Immunomodulators Sales Growth Rate (2016-2020) (MT)
Figure Southeast Asia Immunomodulators Revenue Growth Rate (2016-2020) (MT)
Table Roche Company Details
Table Roche Description and Business Overview
Table Roche Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Roche Immunomodulators Sales Growth Rate (2016-2020)
Table Roche Immunomodulators Sales Market Share in Global Market
Table Roche Recent Development
Table Amgen Inc. Company Details
Table Amgen Inc. Description and Business Overview
Table Amgen Inc. Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Amgen Inc. Immunomodulators Sales Growth Rate (2016-2020)
Table Amgen Inc. Immunomodulators Sales Market Share in Global Market
Table Amgen Inc. Recent Development
Table Abbott Company Details
Table Abbott Description and Business Overview
Table Abbott Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Abbott Immunomodulators Sales Growth Rate (2016-2020)
Table Abbott Immunomodulators Sales Market Share in Global Market
Table Abbott Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Johnson & Johnson Immunomodulators Sales Growth Rate (2016-2020)
Table Johnson & Johnson Immunomodulators Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Novartis AG Immunomodulators Sales Growth Rate (2016-2020)
Table Novartis AG Immunomodulators Sales Market Share in Global Market
Table Novartis AG Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Eli Lilly and Company Immunomodulators Sales Growth Rate (2016-2020)
Table Eli Lilly and Company Immunomodulators Sales Market Share in Global Market
Table Eli Lilly and Company Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Description and Business Overview
Table Bristol-Myers Squibb Company Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Bristol-Myers Squibb Company Immunomodulators Sales Growth Rate (2016-2020)
Table Bristol-Myers Squibb Company Immunomodulators Sales Market Share in Global Market
Table Bristol-Myers Squibb Company Recent Development
Table Merck & Co. Inc. Company Details
Table Merck & Co. Inc. Description and Business Overview
Table Merck & Co. Inc. Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Merck & Co. Inc. Immunomodulators Sales Growth Rate (2016-2020)
Table Merck & Co. Inc. Immunomodulators Sales Market Share in Global Market
Table Merck & Co. Inc. Recent Development
Table Biogen Company Details
Table Biogen Description and Business Overview
Table Biogen Immunomodulators Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Biogen Immunomodulators Sales Growth Rate (2016-2020)
Table Biogen Immunomodulators Sales Market Share in Global Market
Table Biogen Recent Development
Figure Immunomodulators Value Chain
Table Immunomodulators Distributors List
Table Immunomodulators Customers List
Table Global Immunomodulators Sales Forecast 2021-2027 (MT) & (Million US$)
Figure Global Immunomodulators Sales Forecast 2021-2027 (MT)
Figure Global Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Table Global Immunomodulators Sales Forecast by Type 2021-2027 (MT)
Figure Global Immunomodulators Sales Forecast by Type 2021-2027 (MT)
Figure Global Immunomodulators Sales Market Share Forecast by Type 2021-2027
Table Global Immunomodulators Sales Forecast by Application 2021-2027 (MT)
Figure Global Immunomodulators Sales Forecast by Application 2021-2027 (MT)
Figure Global Immunomodulators Sales Market Share Forecast by Application 2021-2027
Table Global Immunomodulators Sales Forecast by Regions 2021-2027 (MT)
Figure Global Immunomodulators Sales Forecast by Regions 2021-2027 (MT)
Figure Global Immunomodulators Sales Market Share Forecast by Regions 2021-2027
Table Global Immunomodulators Revenue Forecast by Regions 2021-2027 (MT)
Figure Global Immunomodulators Revenue Forecast by Regions 2021-2027 (MT)
Figure Global Immunomodulators Revenue Market Share Forecast by Regions 2021-2027
Figure United States Immunomodulators Sales Forecast 2021-2027 (MT)
Figure United States Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Figure European Union Immunomodulators Sales Forecast 2021-2027 (MT)
Figure European Union Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Figure China Immunomodulators Sales Forecast 2021-2027 (MT)
Figure China Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Figure Japan Immunomodulators Sales Forecast 2021-2027 (MT)
Figure Japan Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Figure Korea Immunomodulators Sales Forecast 2021-2027 (MT)
Figure Korea Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Figure India Immunomodulators Sales Forecast 2021-2027 (MT)
Figure India Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Immunomodulators Sales Forecast 2021-2027 (MT)
Figure Southeast Asia Immunomodulators Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources